With our Paladin holding a solid 20% in the money, we are recommending a 40% trim to the company specific play and switch to the broader and safer URNM ETF holding to remain involved in the Uranium/Nuclear power thematic.
Metallurgical and thermal coal producer New Hope is positioned well for long-term organic growth with strong relationships with existing international trading partners like Japan and the slow pace of the “green transition”
with the ASX200 underperforming the S&P 500 by the most in 18 months we are recommending a BUY of the leveraged long ASX200 and a short in the S&P500
Despite the geopolitical pressure, the Timor approval and WDS merger talk, STO has struggled to fund a bid. Conversely, the recent coal import numbers from China showed a 35% increase in coal imports
CSL continues to rally @ $281. Original position was 8% allocation. Today trim another 2% to take down to 4% allocation.
Add Telix Pharma (TLX) in our balanced portfolio, capitalizing on Telix’s innovative cancer treatment advancements and market potential.
The Nasdaq hedge is unlikely to work over the short-term as the thesis of the rate hiking cycle being finished, combined with the 70% occurrence of a “Christmas Rally”
Investing 1% of our portfolio allocation in PLS presents a compelling opportunity. PLS stands as the most shorted stock on the ASX, with a substantial 20.45% short interest. This indicates potential for a short squeeze, which could lead to a rapid price increase.
URNM provides exposure to leading global companies involved in the mining, exploration, development and production of uranium, modern nuclear energy, or that hold physical uranium or uranium royalties
Sell 2.5% holding in Ventia services for 10% profit
The CSL position that we put on initially is now 10% in the money. We are looking to trim 2% or 1/4 of our position to take a profit.
